Can Harvard retain key cancer grant?

Leaders at the Dana-Farber Cancer Institute remain tight-lipped about whether federal officials will renew a major grant for cancer research across Harvard Medical School, Harvard School of Public Health, and five of its teaching hospitals including Dana-Farber -- seen as a major test of whether these ultra-competitive institutions actually can cooperate on research projects. (Full article: 544 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

• $4.95 1 article
• $9.95 4 articles
• $25.95 Monthly